Publications by authors named "M E Fromm"

Objectives: Urinary steroid profiling after hydrolysis of conjugates is an emerging tool to differentiate aggressive adrenocortical carcinomas (ACC) from benign adrenocortical adenomas (ACA). However, the shortcomings of deconjugation are the lack of standardized and fully validated hydrolysis protocols and the loss of information about the originally conjugated form of the steroids. This study aimed to evaluate the quality of the deconjugation process and investigate novel diagnostic biomarkers in urine without enzymatic hydrolysis.

View Article and Find Full Text PDF

Most tight junction (TJ) proteins build epithelial and endothelial barriers [...

View Article and Find Full Text PDF
Article Synopsis
  • - The AMBORA trial showed the benefits of a pharmacological care program for adults using oral antitumour therapeutics (OAT), but similar tailored support for pediatric patients was lacking, leading to the development of the youngAMBORA program.
  • - This program was designed using both quantitative data on the types of cancers and OAT used in a pediatric cancer center, and qualitative surveys to gauge the needs of patients, caregivers, and healthcare providers regarding medication application and side effects.
  • - Key findings revealed that leukemia is common among pediatric patients, with many expressing a desire for education about oral medication; the program will provide counseling, child-friendly medication support, and evaluate 17 relevant side effects, including some previously unrecognized. *
View Article and Find Full Text PDF

Aims: Previous work has identified several limitations in "Summaries of Product Characteristics" (SmPCs), which are associated with risks for patients. The aim of this study was to evaluate pharmacists' and physicians' interpretation of contraindications in SmPCs and reasons for their nonadherence in clinical routine.

Methods: For 20 commonly missed or ignored absolute contraindications, an anonymous online survey providing 24 clinical example cases (one or two per contraindication) for physicians and pharmacists was developed.

View Article and Find Full Text PDF

Background: Search engines often serve as a primary resource for patients to obtain drug information. However, the search engine market is rapidly changing due to the introduction of artificial intelligence (AI)-powered chatbots. The consequences for medication safety when patients interact with chatbots remain largely unexplored.

View Article and Find Full Text PDF